Department News

Lawrence Snyder, MD, PhD, is part of a new study in Nature Communications that demonstrates that artificial neurons can function as trans-functional devices (transneurons) that reconfigure their behavior to attain instantaneous computational needs, each capable of emulating several biological neurons.

Harrison Gabel, PhD, collaborative partnership awarded grant through 2025 Natural History Study Small Grant Program.

Wendy Bridges is the new business director for the WashU Medicine Department of Neuroscience.

Gaia Tavoni, PhD, and Kaining Zhang, PhD, have published a new paper that offers insights into the memory capacity of brain-inspired networks.

Harrison Gabel, PhD, and Hysell Oviedo, PhD, are part of a team of WashU Medicine researchers who have received an $11.85 million NIH grant.

In a study published June 12 in The Journal of Neuroscience, WashU researchers show how they used optogenetics in the larval zebrafish to map the connectivity and activity of V2b neurons, a major inhibitory spinal population, to receive the results.

Jason Yi, PhD, received a $400,000 pilot grant from the Eagles Autism Foundation to advance a new approach to treating autism spectrum disorder.

Tom Franken, MD, PhD, has recent papers published in iScience and Neuron that add new knowledge to how the brain processes complex visual input.

Thomas Papouin, PhD, assistant professor of neuroscience, is the senior author of a groundbreaking study published May 15 in Science.

Join the WashU Medicine Department of Neuroscience on Sept. 8-9 for the David Van Essen Symposium: Insights Into the Cortex, a tribute to the 80th birthday of Van Essen.

Jason Yi, PhD, an assistant professor of neuroscience, is acknowledged for his work with the Angelman Syndrome Foundation and his hands-on, compassionate approach to the syndrome’s community.

Christina Gurnett, MD, PhD, and Lawrence Salkoff, PhD, are lead authors on a case report that describes how Prozac can be used in the treatment of children with rare forms of epilepsy.

Study in mice shows motivation can be restored with targeted treatments.

In a study published April 11 in Science, Adam Kepecs, PhD, and other WashU Medicine researchers report they discovered a previously unrecognized pathway in the brain that senses inflammation and actively suppresses dopamine — a key driver of motivation — resulting in apathy and loss of drive.

Hysell Oviedo, PhD, has been installed as the Roger M. Perlmutter Career Development Assistant Professor of Biomedical Research.

Cheng Huang, PhD, has won a Whitehall Foundation grant to study the neural mechanisms of prediction using Drosophila (fruit flies) as a powerful model to understand analogous processes in the human brain.

Tom Franken, MD, PhD, has received a Young Investigator Grant from the Brain & Behavior Research Foundation (BBRF) to fund a new direction in his research on the neural mechanisms of perception.

In Frontiers in Pharmacology, Lawrence Salkoff, PhD, and colleagues report how norfluoxetine, a long-lasting metabolite of fluoxetine that may accumulate in the brain at greater concentrations than fluoxetine itself in patients treated with fluoxetine, is most likely the agent bringing relief to the patients.